RESEARCH STUDY

The Eye Clinic of Texas is conducting a research study for people with dry eye disease.  The purpose of this research study is to develop a better understanding of the natural history of dry eye disease.

To be eligible for this research study, you must

  • Be at least 55 years old if male or, if female, at least 40 years old with perimenopausal symptoms (or post menopausal)
  • Have dry eye disease
  • Have moderate to severe eye surface discomfort and symptoms of unhealthy tears
  • Be willing to attend 6 study visits over a period of 24 months
  • NOT have a history of herpes keratitis, varizella zoster, or allergic conjunctivitis
  • NOT use or plan to use topical glaucoma medications during the course of the study
  • NOT have had cataract surgery, LASIK, LASEK, or PRK procedure within the past 12 months

We are also studying people who do not have dry eye disease.  To be eligible to participate in this portion of the study, you must

  • Be at least 55 years old if male or, if female, at least 40 years old with perimenopausal symptoms (or post menopausal)
  • Be willing to attend 6 study visits over a period of 24 months
  • NOT have symptoms of dry eye disease
  • NOT have a history of herpes keratitis, varizella zoster, or allergic conjunctivitis
  • NOT use or plan to use topical glaucoma medications during the course of the study
  • NOT have had cataract surgery, LASIK, LASEK, or PRK procedure within the past 12 months

 If you are eligible for this study, you will receive eye exams at no cost to you and you may receive compensation for your time.   There may be reasons why you would not be eligible to participate, and we will discuss this with you.   If you are interested in learning more about this research study, please contact a member of our office staff.

The Failure of the Shuttle to Return Home

There is no place that is or was more committed to the space program of the United States or to the Orbital Shuttle and the space station than the Johnson Space Center in Houston, Texas. John Kennedy traveled to Houston to announce to the world that the United States would put a man on the moon. When that man landed on the moon, his message was directed to Houston. In fact, all significant messages from space were addressed to Houston. It is unconscionable that Houston should not be given a shuttle to memorialize the commitment that this community and its people have made to the space program of our country.

The Merger of Alcon and Novartis has been Completed 

Alcon and Novartis have announced the completion of their merger. This is a very significant event in the ophthalmic world.  Alcon was already a leader is providing pharmaceuticals, lasers, and intraocular lenses. As Kevin Buehler, head of Alcon stated, “Through this merger, Alcon now truly serves the full lifecycle of patient needs across acute and chronic eye diseases, ophthalmic conditions treated with surgical procedures, and multiple options to address the correction of refractive error.” 

We have had a longstanding relationship with Alcon. Our excimer lasers are all manufactured and maintained by Alcon and much of the surgical equipment that we use at the surgery centers are manufactured by Alcon. In addition, we use Alcon intraocular lenses. Because of this, we are really excited about the merger and know that Novartis will be able to support expanded research and development which will inevitably result in new products that will help our patients.

 This is an exciting event for ophthalmology and our patients and we look forward to our future

Bernie’s Burble-

Many of us at The Eye Clinic of Texas attended an event supporting Texas Equusearch and Tim Miller last night. There were close to 600 people who had a very enjoyable evening hearing about the remarkable work that Mr. Miller and his organization, Texas Equusearch, are doing. Mr. Miller explained how and why he started Texas Equusearch.

Several weeks ago, I had the pleasure of interviewing Mr. Miller and he went into great detail about the loss of his daughter, Laura, and how it affected his life. When Laura was finally found, Mr. Miller made a commitment to her to help others who are in a similar situation. What is evident is that Mr. Miller is genuine in his feelings and his commitment to help others. He is a real hero and his story is incredible.

This interview is available for viewing on our website – ECOT.com. I would recommend it to anyone who is interested in Mr. Miller and his wonderful organization 

Sequent Energy Management Presents Texas EquuSearch Sports Extravaganza — April 9, 2011

Sequent Energy Management presents Texas EquuSearch Sports Extravaganza Banquet and Charity Auction benefiting Texas EquuSearch. The Event will be held on April 9, 2011. The Event is being held at Campbell Hall, Pasadena Fairgrounds, 7902 Fairmont Parkway, Pasadena, Texas 77507. Our Special Guest Star will be 7-time Pro Bowler and NFL Defensive Player of the Year, Ed Reed of the Baltimore Ravens.  The Master of Ceremonies is going to be Dave Ward, Anchor of local ABC, KTRK of Houston, TX.  La Brisa Mexican Bar and Grill will be catering the Event, and live music will be performed by The Tony Hill Band and the Auctioneer is Mr. Bear Hebert.

Tim Miller is a patient and a close personal friend of The Eye Clinic of Texas and we are extremely honored to attend this benefit.

WHAT’S HAPPENING NATIONALLY

During my long career in ophthalmology, I’ve been proud to play a leading role in many regional, state-wide, and national organizations dedicated to cutting-edge eye care.

Recently, I attended the American Society of Cataract and Refractive Surgeons’ meeting in San Diego.  ASCRS (pronounced ascris), is a group of some 5,000 ophthalmologists who meet annually to review what is happening in the world of eye surgery.  I served on their founding board and continue to play a role in the organization.

At the April meeting, I had the opportunity to formally review 50 of the best papers presented and then to discuss their importance at a seminar called the Clinical Carryout Session.  I shared this unique opportunity – and honor – with seven other ophthalmologists from around the country.

The essence of the general meeting and the Carryout Session is this:  impressive and imaginative improvements and innovations are being made continually in eyecare.  An amazing amount of money and energy is being spent to research and develop new and improved treatments for people with cataracts as well as for people who do not want to wear glasses or contacts.

The future is bright and clear. This is an exciting time to be an ophthalmologist and to be able to help people see better and continue to see well.

Bernie Milstein

The Voice of Van- I recently attended the  American Society of Cataract and Refractive Surgeon (ASCRS) meetings in San Diego and I am very excited to learn of this new technology available for our glaucoma patients.  I attended a full day of glaucoma lectures.  One new thing about glaucoma treatment is the use of Ex-PRESS shunt in glaucoma surgery. It is a relatively new device that aids ophthalmologist to control eye pressures better for patients who have maximized their eye drop treatment.  It’s inserted in the eye as a surgical procedure.  The fluid inside the eye is shunted through this mini tube and drains to the conjunctival layer of the eye.  The Ex-PRESS gives a more precise control of the fluid level and thus, controls the eye pressure better.  The goal of this device is to reduce or eliminate the use of eye drops and better control the eye pressures.

Dr. Da-Thuy Van, D.O.

WELCOMING DR. STEFAN TROCME

We are happy to have Dr. Stefan Trocme on our team.  Dr. Trocme is a Board Certified ophthalmologist here from Sweeden to head up a research study to help people with dry eye disease.

Dr. Trocme specializes in:

  • treatment of the cornea – dry eye, ocular allergies, ocular inflammation, and eye infections;
  • anterior segment surgery – cataract and pterygium; and
  • refractive surgery – LASIK and PRK.

Dr. Trocme is the former Director of Ocular Surface Services at Case Western

Reserve University Hospital in Cleveland, Ohio, the former Director of Cornea Services at UTMB in Galveston, and he has participated in numerous clinical trials for the treatment of ocular infection, dry eye, and cataracts.